National brain tumour research funding needs to increase to £35 million a year
Data shows big increase to blood cancer survival rates
The proportion of children and young people surviving leukaemia and lymphoma has increased, according to data from the National Cancer Registration and Analysis Service.
The statistics, as reported in a blog by Blood Cancer UK, show that between 1997 and 2001, 79% of children and young people with blood cancer (from birth to 24) survived (as measured by five-year survival). Between 2012 and 2016, that figure had increased to 89%. That means between 2012 and 2016, around 700 children and young people with blood cancer in the UK were saved because treatments had improved since the late 1990s.
The survival rate for children and young people with lymphoma increased from 87% to 93% during this period. For leukaemia, rates increased from 79% for children aged up to 14 and 56% for 15–24-year-olds, to 88% and 76% respectively.
As a member of the Children and Young People with Cancer Coalition (CYPCC), Brain Tumour Research welcomes this good news and congratulates Blood Cancer UK on the role it has played in funding research to help improve treatments for childhood leukaemia.
Between 2002 and 2020, national funding for research into leukaemia was £522 million compared to £110 million for brain tumours. If we are to improve survival rates for brain tumour patients, the national investment into brain tumour research needs to increase to £35 million a year to be in line with other cancers.
- Increase in childhood cancer survival rates masks rising numbers of children lost to brain tumours
- Take part in Wear A Christmas Hat Day
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.